Postsurgical Intestinal Rehabilitation Using Semisynthetic Glucagon-Like Peptide-2 Analogue (sGLP-2) at a Referral Center: Can Patients Achieve Parenteral Nutrition and sGLP-2 Independency?

Héctor SolarMariana DoeyoMariana OrtegaSilvia De BarrioEstela OlanoEduardo MoreiraMartin BuncugaAlejandra ManzurAdriana CrivelliGabriel E Gondolesi

Published in: JPEN. Journal of parenteral and enteral nutrition (2020)

This study confirmed that sGLP-2 should be considered as part of the standard therapy for postsurgical medical rehabilitation treatment in patients with chronic intestinal failure. We add to the current knowledge that some patients can discontinue both PN and sGLP-2 in the long term, achieving complete recovery of their quality of life.

Keyphrases

end stage renal disease
healthcare
ejection fraction
newly diagnosed
peritoneal dialysis
prognostic factors
smoking cessation